Results of a prospective dose intensity and neutropenia prophylaxis evaluation programme (DIEPP) in cancer patients at risk of febrile neutropenia due to myelosuppressive chemotherapy
Crossref DOI link: https://doi.org/10.1007/s00508-015-0917-1
Published Online: 2016-01-08
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mądry, Radosław
Popławska, Lidia
Haslbauer, Ferdinand
Šafanda, Martin
Ghizdavescu, Doru
Benkovicova, Jana
Csőszi, Tibor
Mihaylov, Georgi
Niepel, Daniela
Jaeger, Christine
Frkanova, Iveta
Macovei, Alina
Staudigl, Christine
License valid from 2016-01-08